Endogenous Transposase Source in Human Cells Mobilizes piggyBac Transposons.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. The Past, Present, and Future of Non-Viral CAR T Cells.Frontiers in immunology · 2022
   Review
2. In VivoInternational journal of molecular sciences · 2019
   Article
3. The impact of transposable element activity on therapeutically relevant human stem cells.Mobile DNA · 2019
   Review
4. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
   Article
5. Manufacture of CAR-T cells in the body.Nature biotechnology · 2017
   Article

Corrections and comments

• Comment on
  Genomic DNA transposition induced by human PGBD5.2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as